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NOical isolates of dengue virus were selected according to their susceptibility to the
inhibitory effect of nitric oxide radical, NO. Five of them are nitric oxide-susceptible viruses while the other
ﬁve are nitric oxide-resistant viruses. These isolates were investigated to identify genetic factors that are
responsible for the different phenotypes. Due to the evidence showing that NO suppresses DENV RNA
polymerase activity, we, therefore, hypothesized that the RdRp domain of NS5 may responsible for NO
inhibition. To answer this question, sequences of NS5 gene of NO-susceptible viruses and NO-resistant
viruses were compared. We found that these two groups of viruses contain different amino acid sequence at
position 621 to 646 in the active site of NS5. These data suggested that response to the inhibitory effect of
nitric oxide radical may, at least in part, be regulated by NS5. The effect of these two different phenotypes of
viruses on host cells was studied using cDNA array screening. The cDNA array analysis demonstrated that the
nitric oxide-resistant group had a stronger inﬂuence on host cells since it induced changes in the expression
of a greater number of genes than did the nitric oxide-susceptible group, 97 genes versus 71 genes,
respectively. The NO-resistant virus also stimulated cytokines known to be virulent factors, such as IL 6, IL 8,
RANTES, and the inﬂammatory factors. In conclusion, our data demonstrated that dengue viruses isolated
from patients show genotypic and phenotypic differences which may correlate with virulence.
© 2008 Elsevier Inc. All rights reserved.Introduction
Dengue is the most common arthropod-borne viral disease
caused by a single-stranded, positive-sense RNA virus of the genus
Flavivirus named dengue virus (DENV). Infection by DENV can
cause a subclinical infection or an illness with severity ranging
from ﬂu-like symptoms to classical dengue feverwith or without life-
threatening manifestation. The classical dengue fever, DF, is a self-
limiting illness with an abrupt onset of fever, headache, retro-ocular
pain, muscle and joint pain, nausea, vomiting and rashes that may be
associated with moderate hemorrhagic manifestations. It is esti-
mated that less than 3% of symptomatic patients develop a life-
threatening syndrome presenting with hemorrhage and shock, the
dengue hemorrhagic fever or DHF (Halstead, 1980). Severe clinical
manifestations are believed to be the result of a complex interplay
between different factors including viral strain, circulating viral
particles and viral antigens, the host, and the vector. This has been
extensively reviewed elsewhere (Pang et al., 2007; de la C Sierra et al.,
2007; Halstead, 2008).
DENV is composed of four genetically and antigenetically related
serotypes. Each serotype of DENV contains abundant genetic variationl rights reserved.and can be subdivided into subtypes or genotypes. Among those ge-
notypes, the Southeast Asian genotype presents the greatest amount
of genetic diversity (Holmes, 2006). This genotypic variation may
partly explain the differential severity of clinical symptoms in a
dengue-immune population, as shown by epidemiological observa-
tions (Kouri et al., 1998; Rico-Hesse et al., 1997). For example, the
Southeast Asian genotype, but not its American counterpart, is
frequently associates with severe infection (Watts et al., 1999). Even
though the genetic basis of this difference is unclear, the two ge-
notypes differ by ten charged amino acids in both structural and
nonstructural proteins. Some of these differences affect replication
efﬁciency and transmission rate in human cell, the primary target, and
the mosquito vector (Cologna et al., 2005; Cologna and Rico-Hesse,
2003).
We recently showed that sensitivity to the inhibitory effect of nitric
oxide radical might be another criterion to distinguish clinical isolates
of dengue viruses since replication of 60% of clinical isolates, 24 out of
40 isolates, were suppressed in the presence of nitric oxide, NO,
synthesized from 50 µM SNAP while the remaining 16 isolates repli-
cate unaffectedly under the same treatment (Charnsilpa et al., 2005).
The target of nitric oxide on dengue virus replication is unclear but
there is evidence suggesting that this free radical may exert its in-
hibitory effect through inhibition of RdRp activity (Takhumpanya
et al., 2006). Given that some target cells of the virus, such as
Fig. 1. Replication kinetics of NO-resistant and NO-susceptible isolates in the presence
and absence of iNOS inhibitor, L-NIL. THP-1 cell cultureswere infectedwith either group
of isolates at the MOI of 1.0. Virus productionwas monitored up to ﬁve days of infection
in the presence or absence of L-NIL (a). The level of NO production in the culture
medium was determined by using a colorimetric kit (b). Three independent experi-
ments were performed and data are shown as mean±SD. (⁎) indicates statistically
signiﬁcance at P value less than 0.05.
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viruses in vulnerability to nitric oxide may affect the clinical outcome
of patients.
In the present study, 10 isolates of dengue virus from DF and DHF
patients, 5 isolates from each, were investigated. The 5 DF isolates are
NO-sensitive viruses while the other 5 DHF isolates are NO-resistant.
The genotypic differences of the NS5 gene between these two groups
were investigated at the level of amino acid sequence. In addition,
differences in global gene expression of NO-producing host cells in
response to infection by the two groups of isolates were monitored
using a cDNA array analysis. We demonstrate that the response of the
dengue virus to the inhibitory effect of free radical may be regulated
by the NS5 gene. We also show here that NO-resistant viruses have a
stronger inﬂuence on gene expression of the infected host cells in
both the number and the type of genes. The relationship between the
gene expression patterns and the clinical manifestations of viral
isolates is discussed.
Results
The effect of endogenous nitric oxide on the replication of NO-susceptible
and NO-resistant DENV-2
The kinetics of replication of these two groups of clinical isolates
was investigated in THP-1 cells in the presence or absence of 100 µM
L-NIL, a speciﬁc inhibitor of iNOS. As demonstrated in Figs. 1a and b,
NO-susceptible isolates replicated less efﬁciently than the NO-
resistant viruses in the presence of endogenous NO synthesized
from infected THP-1 cells. However, these two groups of viruses
replicated equally well when endogenous NO synthesis was sig-
niﬁcantly suppressed in the presence of 100 µM L-NIL (Figs.1a and b).
These results indicate that nitric oxide has a profound effect only on
the replication of NO-sensitive dengue viruses but not on NO-
resistant viruses.
NS5 is responsible for susceptibility to nitric oxide
Our previous report suggests that NO might exert its inhibitory
effect through suppression of NS5 activity (Takhumpanya et al.,
2006). We, therefore, hypothesized that amino acids in the virus
genome, particularly in the active site of NS5, might determine the
resistance/sensitivity to NO. To answer this question, amino acids
responsible for resistance/sensitivity to NO were predicted. Two
domains of NS5, amino acid 211 to 458 in the MTase domain and
amino acid 598 to 749 of the active site of RdRp domain, were
sequenced (Yap et al., 2007). These were then aligned with the
published sequence of DENV-2 (Asian I genotype, Vietnam strain)
using BioEdit (Version7.0.5.2). As shown in Fig. 2a, differences of
amino acid sequence at position 621 to 646 were found between
susceptible and resistant groups and among viruses within the
resistant group. The sequences of amino acid 211 to 458 in the MTase
domainwere also aligned and a strong homology was found (Fig. 2b).
These data suggested that NS5 domain 621 to 646 may be, at least in
part, responsible for the different phenotypes.
cDNA array analysis of gene expression proﬁle in THP-1 cells infected
with either NO-susceptible or NO-resistant isolates
The above data suggests that the efﬁciency of replication of these
two groups of isolates is different in NO-producing THP-1 cells. To
verify the impact of these two groups of isolates on host responses, the
cDNA analysis was used to compare the patterns of THP-1 gene
expression in response to infection by either of these two groups of
viruses. Genes that exhibited twofold increase or decrease in ex-
pression against the uninfected THP-1 control cells in three indepen-
dent experiments were considered signiﬁcant (Table 1). Among thedysregulated genes, twelve were affected by both groups of virus
isolates while 59 were affected only by the NO-susceptible DENV and
85 only by the NO-resistant DENV.
Since pathophysiology of DENV infection is mainly affected by
immunological mediators, we focused on the alteration in immune
response genes. Tables 2 and 3 show the list of immune response
transcripts on the cDNA array that were activated or suppressed by
either group of viruses. The expression of 21 and 41 immune
response-related genes was affected by the infection of NO-suscep-
tible and NO-resistant viruses, respectively.
These results indicate that the NO-resistant viruses have a bro-
ader effect on THP-1 gene expression than do the NO-susceptible
viruses.
Validation of cDNA array analysis by RT-PCR
To validate the cDNA array data, 13 genes (CD40L, DAF, IL-3R, IL-4R,
IL-6, IL-8, IRF-2, LFA-3, NK4, PBP, ELAM-1, GP-1A and GP-3A) were
selected for RT-PCR analysis. THP-1 cells were infectedwith either NO-
resistant or NO-susceptible virus or mock-infected. Then, the expres-
sion levels of selected genes were determined on day 3 of infection.
The observed expression levels relative to β-actin gene expression are
shown in Table 4. The level of gene expression detected by RT-PCR
conﬁrmed the up- or down-regulation of these 13 genes as demon-
strated by cDNA array analysis.
Fig. 2. a. Amino acid sequences of active site of RdRp of NO-sensitive viruses. (S1–S5) and NO-resistant virus (R1–R5) were aligned to the same region of DENV-2, Asian I genotype,
Vietnam strain (accession # ACA48717). b. Amino acid sequences of MTase domain of NO-sensitive viruses (S1-S5) and NO-resistant viruses (R1-R5) were aligned to the same region
of DENV-2, Asian I genotype, Vietnam strain.
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To conﬁrm the array data at the protein level, production of IL-6
and RANTES in culture supernates from uninfected and virus-infectedTHP-1 cells were quantitated by ELISA. As demonstrated in Figs. 3a–b,
IL-6 and RANTES productions were stronger in NO-resistant infected
cells than in NO-susceptible infected cells. These data agree with the
cDNA array expression detection.
Table 2
List of immune response genes and immune response-related genes with expressions
suppressed or stimulated by NO-susceptible viruses
Gene description Fold change (±S.D.)
Up-regulation
Platelet membrane glycoprotein IA precursor (G-PIA) 5.0±2.4
B-cell antigen receptor complex-associated protein
beta-subunit precursor
10.5±3.3
Granulocyte colony stimulating factor receptor (GCSF-R) 6.2±4.0
Interleukin-4 receptor alpha subunit (IL-4R) 47.5±25.1
Interleukin-3 receptor alpha subunit (IL-3R) 26.0±17.4
CD40 ligand (CD40-L) 43.5±26.2
HLA class I histocompatibility antigen C4-alpha subunit (HLAC) 6.4±3.6
HLA-B-associated transcript 2 2.0±1.3
Granzyme K (GZMK) 10.3±5.1
Eosinophil peroxidase (EPO; EPP) 12.1±5.2
B-cell lymphoma 3-encoded protein (bcl3) 39.6±16.1
Down-regulation
L-selectin 0.25±0.1
LFA-1 alpha subunit 0.48±0.2
CD69 antigen 0.22±0.1
CC chemokine receptor type 9 (CCR9) 0.19±0.04
Interleukin-9 receptor type (IL-9R) 0.28±0.1
Interleukin-5 receptor type alpha (IL-5R) 0.17±0.02
TGF-beta receptor type III (TGFR-3) 0.49±0.2
Interferon regulatory factor 2 (IRF-2) 0.2±0.1
Signal transducer and activator of transcription 6 (STAT6) 0.02±0.01
Signal transducer and activator of transcription 2 (STAT2) 0.09±0.05
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Each year, more than 50 million people are infected by DENV and
around 500,000 cases develop a severe disease, DHF/DSS (World
Health Organization, 2002). Several models have been proposed to
explain the progression of clinical manifestation into the severe form.
These models focus on the role of host and viral factors in increased
pathogenesis (Green and Rothman, 2006). Our present report gives
another piece of evidence for the role of viral factor on the severity of
dengue infection. Two groups of low passages of clinical isolates
which express a distinct phenotype on response to nitric oxide radical
were investigated in the present study. We found that these clinical
isolates behaved differently in NO-producing target cells, THP-1. The
NO-resistant group replicated more efﬁciently than those NO-
sensitive viruses. Our sequencing data revealed signiﬁcant differences
on amino acid composition in one domain of an active site of NS5
suggesting that NS5 is one part of genetic factor that determines NO-
sensitive or NO-resistant phenotype. The present data supports
evidence demonstrated by Takhumpunya et al that NS5 might be a
target of NO (Takhumpanya et al., 2006).
The NO-resistant viruses had stronger inﬂuence on host genetic
response than did the NO-susceptible ones. Higher replication and
stronger inﬂuence on the global host gene expression are character-
istics found in virulent DENV (Rabablert et al., 2007; Butrapet et al.,
2000; Yoksan et al., 1986). Whether NS5 determines severity of DENV
infection or not remains to be elucidated. The investigation of DENV
evolution in Cuba found dominant nucleotide substitution in NS5 but
not in structural genes during a severe dengue epidemic in 1997
(Rodriguez-Roche et al., 2005). Thus, in order to draw a correlation
between the NS5 genotype and its contribution to disease severity,
more investigation on NS5 genetic manipulation is required.
To further distinguish between the two groups of clinical isolates,
differences in viral-host interaction were investigated at the genomic
level. The cDNAdata indicated thatNO-resistant isolates had a stronger
inﬂuence on the expression of immune response-related genes than
did NO-susceptible isolates. The NO-resistant virus up-regulated cyto-
kines/chemokines genes and genes involving an activation of T cells,
B cells, platelets, and inﬂammatory cells. Functions of these mediators
may result in the interaction between platelets, vascular endothelial
cells, and inﬂammatory cells (Martin et al., 2007). This interaction is
critical for the vascular events including vascular leakage.
Another striking difference between the two groups of isolates is
that NO-resistant isolates signiﬁcantly up-regulated IL-6, IL-7, IL-8,
RANTES, and MCP-3. These factors have been shown to be correlated
with an increased dengue pathogenesis through various mechanisms.
IL-6, in its high concentration, plays a crucial role in the enhanced
production of anti-platelet or anti-endothelial cell auto-antibodies, an
elevated level of tPA, as well as a deﬁciency in coagulation (Akira et al.,
1993). A high level of plasma IL-6 is found in DHF/DSS patients but not
in DF patients (Nguyen et al., 2004; Lee et al., 2007). A study on DENV
infection of human primary lung epithelial cell in vitro suggests that
IL-6 may be involved in plural effusion and hemorrhage through the
induction of sPLA2 synthesis by lung epithelial (Lee et al., 2007). IL-8
destroys tight-junction and cytoskeleton reorganization, resultingTable 1
Comparison of altered gene expression in THP-1 cells 3 days of viral infection
Infections Numbers of genes
Dysregulated genes Same genesa Different genesb
NO-susceptible DENV 71 12 59
NO-resistant DENV 97 12 85
a Genes that were up- or down-regulated by both groups of DENV isolates.
b Genes that were up- or down-regulated by either NO-susceptible DENV or NO-
resistant DENV infection.in increased permeability of microvascular endothelial monolayers
during DENV infection (Tabavera et al., 2004).
RANTES is a chemokine that is synthesized by various types of cells
infected by DENV (Suksanpaisan et al., 2007; Huang et al., 2000). This
chemokine induces NK cells activation, and serves as a chemotaxis
which stimulates trans-endothelial migration of various inﬂammatory
cells (Appay and Rowland-Jones, 2001;Middleton et al., 2002).MCP-3 is
a pleiotropic chemokine that is important in regulating immune cell
trafﬁcking and function (Ali et al., 2005). Signiﬁcant upregulation of
RANTES and MCP-3 gene expression in cells infected with NO-resistant
viruses implies an enhancement of immune cells, including inﬂamma-
tory cells, and themovement to the infected sites where tissue damages
are induced.
These data suggest that NO-resistant isolates preferentially stimu-
lated cytokines/chemokines that are potent mediators of tissue dama-
ging as well as the coagulopathy while the NO-susceptible viruses did
not. The difference may underline intrinsic properties of the clinical
isolates. This observation is supported by the evidence that DENV-in-
duced cytokinepattern is dependenton serotype andstrain (Azizanet al.,
2006). The balance between virus elimination and tissue damaging ef-
fects of these immunemediatorswill determine the severity of infection.
Infection by NO-resistant virusesmarkedly induced genes involved
in immune suppression such as IL-7 and CD83 (Fry and Mackall, 2001;
Luthje et al., 2006). IL-7 is strongly associated with CD4+ T cell
lymphopenia in HIV infected patients and also plays an important role
in the inﬂammation and the immunopathology of rheumatoid ar-
thritis (Napolitano et al., 2006; Hartgring et al., 2006). High expression
of IL-7 and CD83might imply an inefﬁciency in DENV clearance during
an acute phase of infection by the NO-resistant virus.
In conclusion, our present investigation demonstrated that the
patient isolates of DENV-2 have different intrinsic properties which
can be illustrated using efﬁciency of replication and the stimulation
patterns of immune response genes related to increased pathogenesis.
Our observations suggested that clinical isolates of DENV resistant to
NO have a higher potential to cause severe clinical symptoms than did
NO-susceptible isolates. Whether or not these phenotypes are deter-
mined by the differences in genotypic characteristics of NS5 should be
investigated further.
Table 4
Levels of expression of selected genes in NO-susceptible and NO-resistant DENV-
infected THP-1 cells as identiﬁed by cDNA array and RT-PCR
Gene Fold change
cDNA array RT-PCR
NO-susceptible NO-resistant NO-susceptible NO-resistant
CD40L 43.5±26.2 0.6±0.1 4.8±3.1 0.6±0.4
DAF 2.3±1.1 3.9±1.9 2.1±0.74 2.4±1.02
IL3r 26.1±17.4 0.7±0.1 7. 9±0.65 0.7±0.05
IL4r 47.5±25.1 0.77±0.2 5.4±3.3 0.8±0.07
IL-6 0.8±0.2 10.0±2.0 1.1±0.1 6.0±0.06
IL-8 0.91±0.3 13.3±5.0 0.96±0.2 6.99±0.5
IRF-2 0.2±0.01 0.9±0.02 0.4± .2 0.9±0.4
LFA-3 3.4±1.6 4.3±2.0 2.2±0.6 2.6±0.4
NK4 0.3±0.1 0.2±0.03 0.5±0.06 0.30±0.05
PBP 0.2±0.05 0.1±0.08 0.1±0.05 0.3±0.2
ELAM-1 0.9±0.05 3.9±2.1 1.1±0.22 2.5±0.1
GP1A 5.1±2.4 0.6±0.1 3.5±1.4 0.9±0.1
GP3A 0.7±0.2 4.2±2.0 0.8±0.06 3.0±0.06
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Virus and cell culture
Virus
Ten out of 40 isolates previously described by Charnsilpa et al.
were selected for the present study (Charnsilpa et al., 2005). Of the ten
isolates, 5 were NO-sensitive viruses isolated fromDF patients and the
other 5 were NO-resistant viruses isolated from DHF patients. These
viruses were low-passage isolates of DENV-2 obtained from Virology
Department, Armed Forces Research Institute of Medical Science,
Bangkok, Thailand. Viruses from patients were ﬁrst ampliﬁed in Tox-
orhynchitis splendensmosquitoes andwere then ampliﬁed twice in C6/
36 cells.
Cell culture
THP-1 cells were obtained from American Type Culture Collection
(ATCC, Rockwell, MD). The cells were cultured in Iscove-modiﬁed
Dulbecco's medium (IMDM) supplemented with 10% fetal bovine
serum, FBS (Gibco Labs, Grand Island, NY) at 37 °C in 5% CO2
atmosphere.Table 3
List of immune response genes and immune response-related genes with expressions
statistically up- or down-regulated during NO-resistant virus infection
Gene descriptions Fold change (±S.D.)
Up-regulation
Platelet membrane glycogrotein (IIA) (GP3A) 4.2±2.0
CD44 antigen hematopoietic form (CD44H) 4.7±1.9
E-selectin (ELAM-1) 3.9±2.1
Leukocyte adhesion glycoprotein p150 84.3±34.2
Monocyte differentiation CD14 antigen 16.0±4.1
L-selectin 5.3±2.2
Cytotoxic T-lymphocyte protein-4 (CTLA-4) 7.1±2.6
Leukocyte surface CD53 antigen 5.5±1.0
CD9 antigen 3.1±1.4
T-lymphocyte activations CD86 antigen 40.3±15.8
CD83 antigen 14.28±4.3
Beta chemokine exodus 2 4.0±15.8
IL-2 receptor beta (IL2RB) 3.3±1.8
Interleukin 6 (IL-6) 10.0±2.0
Interleukin 7 (IL-7) 5.1±3.1
Interleukin 8 (IL-8) 13.3±5.5
CD27 ligand 15.8±5.4
CSF-1R 3.8±1.3
T cell speciﬁc RANTES 15.21±4.1
Monocyte chemotactic protein 3 (MCP3) 8.1±1.0
Antileukoproteinase 1 (ALP) 17.5±6.4
IgA Fc receptor (FcAR) 14.9±6.6
T cell differentiation CD6 antigen 3.6±1.4
B-cell antigen receptor 35.5±12.3
Signal transducer and activator of transcription 2 (STAT 2) 3.2±1.6
Interferon regulatory factor 4 (IRF-4) 67.13±23.9
T cell maturation-associated protein (MAL) 2.3±1.2
Hematopoietic lineage cell speciﬁc protein 22.8±8.6
Down-regulation
LFA-1 alpha 0.32±0.1
Hemopoietic progenitor cell CD34 antigen 0.3±0.1
Myeloid cell surface CD33 antigen 0.5±0.1
CC chemokine receptor type 2 (CCR2) 0.03±0.01
CC chemokine receptor type 6 (CCR6) 0.48±0.2
Interleukin 2 receptor alpha (IL-2RA) 0.02±0.01
Lymphocyte activation CD30 antigen 0.04±0.02
Macrophage–derived chemokine precursor (MDC) 0.11±0.05
Granulin 0.06±0.02
Complement receptor type 2 0.35±0.1
B-cell receptor CD22 alpha 0.3±0.1
HLA-B –associated transcript 2 0.08±0.03
MHC-II transactivator (CIITA) 0.04±0.01Inoculation of THP-1 culture
NO-susceptible and NO-resistant DENV were inoculated into 106
cells of THP-1 at the MOI of 1.0. After 1.5 h of inoculation at 37 °C, the
infected cells were washed and cultured further in the growth
medium. The supernatants and infected cells were harvested every
24 h for 5 days. Supernatants were then subjected to detection of viral
genome production using real-time RT-PCR, NO production, and
cytokines production by ELISA. Harvested cells were used for cDNA
array analysis and for detection of gene expression by RT-PCR.Fig. 3. Validation of array data using ELISA. The levels of IL-6 (a) and RANTES (b) in
infected culture medium were quantitated using ELISA. Supernatants from the
uninfected cultures were used as controls. (⁎) indicates signiﬁcantly difference at the
P value≤0.05.
Table 5
List of primer sequences for RT-PCR
Gene Accession
Number
Primer (5′→3′)
Forward Reverse
CD40L L07414 GCCAAACCTTGCGGGCAACA GGGTGGGCTTAACCGCTGGTGC
DAF M31516 GAGTGGAGTGGCCCACCACCTGAAT GCCCATGGTTACTAGCGTCCCAAGC
ELAM-1 M30640 AGCTTCCCATGGAACACAAC CACATTGGAGCCTTTTGGAT
GP1A M28249 TCACTTTGTTGCTGGTGCTC TCGGATCCCAAGATTTTCTG
GP3A J02703 GACAAGGGCTCTGGAGACAG TCCGTGACACACTCTGCTTC
IL3R-α M74782 CCCTGAGAACAGTGGGAAGCCTTGG GACACCCGATACGTGTTCCCTGAGC
IL4R-α X52425 GAGGGTCTCTTAGGTGCATGTCC ACTCTCATGGGATGTGGCGAGCCC
IL-6 X04602 GCTGCCTTCCCTGCCCCAGT CTGGTTCTGTGCCTGCAGCTTCG
IL-8 Y00787 AACATGACTTCCAAGCTGGCCGTGGCTC GCGCAGTGTGGTCCACTCTCAATCACTC
IRF-2 X15949 AGCGACGAGCAGCCGGTCAG TGCCGGGCAGCAGGTAGGAG
LFA-3 Y00636 ATTGGATCCCGAGCATGGTTGCTGGGAG AAGTCGACTAGTTCAATTGGAGTTGGTT
NK4 M59807 CCGAGGAGCCTGGGGAGAGC GAACGCCAGGCAGGGGGACT
PBP M54995 GCCTTGCAGGTGCTGCTGCTTC CCAGGCAGATTTTCCTCCCATCC
Β-actin P02570 TGGAATCCTGTGGCATCCATGAAAC TAAAACGCAGCTCAGTAACAGTCCG
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RNA was extracted from culture supernatants using the NucleoS-
pin® RNAVirus Kit (Macherey-Nagel, Germany). The puriﬁed RNAwas
then subjected to RT-PCR using QuantiTect™ Probe RT-PCR (QIAGEN
GmbH, Germany) as described (Houng et al., 2000). RT-PCR ampliﬁca-
tion, data collection and analysis were performed by Rotor-Gene™
3000 (Corbett Research, Sydney, Australia). The RNA copy numberwas
calculated using dengue serotype speciﬁc copy standards kindly
supplied by Dr. Huo-Shu H. Houng, WRAIR (Walter Reed Army Insti-
tute of Research, USA).
Quantitative detection of nitric oxide production
The amounts of nitric oxide in the supernatants were detected by
NO colorimetric Kit (Cayman Chemical Company, Ann Arbor, MI) that
detects the stable products of NO, NO2/NO3. The experiment was
performed according to manufacturer's protocol.
RNA extraction and cDNA array analysis
Total RNA was extracted from DENV-infected THP-1 by using the
Nucleospin RNAII Kit (Macherey-Nagal, Germany) according to
instructions recommended by the manufacturer. The mRNA was iso-
lated from total RNA by using the Streptavidin Magnetic beads System
(Clontech, CA, USA). The puriﬁed mRNA was reverse-transcribed and
labeled with 32P-dATP to synthesize 32P-cDNA probes according to
manufacturer's protocol. The labeled cDNA probes were hybridized to
the BDAtlas™ Human Hematology/Immunology Array (ClonTech). The
expression signal of each gene was detected by autoradiography. The
intensity of spots was analyzed by using ClonTech Atlas Image pro-
gram version 2.7. Normalization was performed by dividing the
intensities of housekeeping genes from each pair of arrays from the
same day post infection, and the value obtained was used as the
intensity coefﬁcient. The adjusted intensities of spots were calculated
by multiplying the spot intensity by the intensity coefﬁcient.
To demonstrate a reliable cDNA array analysis, the reproducibility
of the techniquewas examined and found that the correlation between
two data sets was very high (R2=0.981, P value is ≤0.05), conﬁrming
the high reproducibility of the technique used in this study.
Determination of gene expression by semiquantitative RT-PCR
The levels of gene expression in DENV-infected THP-1 were mea-
sured semiquantitatively by RT-PCR as previously described (Ubol
et al., 1998). Brieﬂy, harvested cells were lysed. RNA was puriﬁed and
subjected to the ﬁrst strand cDNA synthesis before being further
ampliﬁed by PCR. The list of speciﬁc primers for RT-PCR is shown inTable 5. The PCR products were electrophoresed and the density of
each band was measured semiquantitatively with a densitometer. The
levels of gene expressionwere presented as fold changes in transcrip-
tion between either NO-susceptible or NO-resistant DENV-infected
THP-1 cells and uninfected cells by using β-actin as an internal control
for gene expression.
Detection of cytokine production by ELISA
The levels of IL-6, and RANTES production in the supernatants of
infected THP-1 cultures were measured using Quantikine® ELISA kit
(R&D Systems, Inc., Minneapolis, MN). Brieﬂy, 200 µl of standards or
samples were pipetted into wells precoated with polyclonal antibody
speciﬁc to these cytokines. The antibody-cytokine interaction was
detected using enzyme-linked polyclonal antibodies speciﬁc for these
cytokines and the substrate. The intensity of the colorwasmeasured at
450 nm.
Statistical analysis
Values were expressed as mean±standard deviation (SD) of three
independent observations. The signiﬁcance of differences was tested
by Student's t-test, One-way ANOVA or Pearson's correlation. P value
less than 0.05 is considered signiﬁcant.
RNA extraction and RT-PCR to generate NS5 DNA fragments used in
sequencing
Virus RNA was extracted from cell-culture supernatant by using
NucleoSpin® RNA Virus Kit (MACHEREY-NAGEL, Germany) according
to the manufacturer's instruction. Oligonucleotide primers for DEN-2
NS5 gene ampliﬁcation and sequencing were previously described
(Balleotti et al., 2003). Genomic RNA was reverse-transcribed into
cDNA by using random-hexamer primers with the AMV-RT. DENV-2
NS5 gene was ampliﬁed by PCRwith Tag DNA polymerase and the PCR
product was puriﬁed and submitted for DNA sequencing. The primers
for MTase domain are sense 5′ TCA AGG AAC TCC ACA CAT GAG ATG
TACT 3′ and anti-sense 5′ TCT CTC TCT TTC CCA TCA TGT TGT A 3′.
The primer set for RdRp domain is sense 5′ CAG TGG ACA GGT GGG
AAC TT 3′ and anti-sense 5′ TCC TGC TCC CTG AGA GATTC 3′.
The nucleotide sequences obtained were translated, aligned and
analyzed using BioEdit (Version 7.0.5.2) (Hall, 1990).
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